Brief: Prelude Therapeutics Shares Open 32.8% Above IPO Price In Debut On Nasdaq
25/09/2020 16:48
Sept 25 (Reuters) -
* PRELUDE THERAPEUTICS SHARES OPEN AT $25.23 IN DEBUT ON
NASDAQ
VERSUS IPO PRICE OF $19.00/SHARE
Further company coverage: PRLD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prelude Therapeutics Incorporated
See all newsBrief: Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer
U.S. RESEARCH ROUNDUP-Celcuity, Fluence Energy, Salesforce
Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings Summary
Prelude Therapeutics Q2 revenue beats analyst expectations, net loss narrows
Prelude Therapeutics Incorporated expected to post a loss of 20 cents a share - Earnings Preview